Questions discussed in this category

Given the results of ZUMA-7, TRANSFORM, and BELINDA - how does this inform your current practice? What are the currently approved indications for CAR-...

CAR-T (any specific preference of product?) vs bispecific antibodies vs any other specific agents not previously utilized?

Do you limit it to post-pubertal patients? Do you offer it only if they will proceed with bone marrow transplantation after CAR-T?

Papers discussed in this category

N Engl J Med, 2021 Dec 11


Blood, 2020 Sep 23

International journal of radiation oncology, biology, physics, 2019-12-01

The Lancet. Oncology, 2019-01

Molecular therapy : the journal of the American Society of Gene Therapy, 2018-11-07

Cancer immunology research, 2019-07

Br J Haematol, 2020 Mar 5

Lancet, 2020 Sep 01

Blood Adv,

Int J Radiat Oncol Biol Phys, 2020 May 22

J Clin Oncol, 2021 Dec 9

Blood Cancer Discov, 2021 Dec 01

Proc Natl Acad Sci U S A, 2019 Apr 15

N Engl J Med,

Exp Hematol Oncol, 2021 Feb 19

Blood, 2022 Mar 03